Publications by authors named "James Rubenstein"

Claim this Profile
I
Identification of genomic biomarkers of disease progression and survival in primary CNS lymphoma.
Huimin Geng, Shirley Mo, Lingjing Chen, Aishwarya Ballapuram, Mazie Tsang, James L Rubenstein

Blood Adv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathologic features of primary central nervous system anaplastic large cell lymphoma: a multicenter study identifies age and ALK status as prognostic factors.
William Patrick Morrow, Nicholas S Milligan, Robert S Ohgami, Ken H Young, Bangchen Wang, James L Rubenstein

J Hematop· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small molecule protein assembly modulators with pan-cancer therapeutic efficacy.
Anuradha F Lingappa, Olayemi Akintunde, Erin Samueli, Connie Ewald, Maya Michon, James L Rubenstein

Open Biol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of PD-1, PD-L1, and IDO-1 Stains in Ocular Extranodal Marginal Zone Lymphoma (MZL) and Diffuse Large B-cell Lymphoma (DLBCL).
Alexander Craig, Ekin Güney, Melike Pekmezci, Michele Bloomer, Zoltan Laszik, James Rubenstein

Appl Immunohistochem Mol Morphol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO review.
Lakshmi Nayak, Chetan Bettegowda, Florian Scherer, Norbert Galldiks, Manmeet Ahluwalia, James L Rubenstein

Neuro Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101.
Tracy T Batchelor, Sharmila Giri, Amy S Ruppert, Susan M Geyer, Scott E Smith, James L Rubenstein

Blood Adv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular profiling identifies at least 3 distinct types of posttransplant lymphoproliferative disorder involving the CNS.
Ekin Guney, Calixto-Hope G Lucas, Kunwar Singh, Melike Pekmezci, Sebastian Fernandez-Pol, James L Rubenstein

Blood Adv· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers.
Kevin A David, Suchitra Sundaram, Seo-Hyun Kim, Ryan Vaca, Yong Lin, James Rubenstein

Am J Hematol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort.
Prashasti Agrawal, Kevin A David, Zhengming Chen, Suchitra Sundaram, Seo-Hyun Kim, James L Rubenstein

Leuk Lymphoma· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tafasitamab at the blood-brain barrier.
Andreas M Rauschecker, Shirley S Mo, Michael Randall, John Shen-Sampas, James L Rubenstein

Br J Haematol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic Radiosurgery for Primary Central Nervous System Lymphoma.
Susan Y Wu, Steve E Braunstein, James L Rubenstein, Penny K Sneed

Cureus· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary CNS lymphoma: update on molecular pathogenesis and therapy.
Shirley S Mo, Joseph Cleveland, James L Rubenstein

Leuk Lymphoma· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary CNS Lymphoma: Progress With Dose-Intensive Consolidation.
James L Rubenstein

J Clin Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquired factor VII inhibitor associated with primary central nervous system Lymphoma: A case report.
Vanshika Goyal, Giselle Salmasi, Andrew D Leavitt, James L Rubenstein, Rahul Banerjee

EJHaem· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A genetically distinct pediatric subtype of primary CNS large B-cell lymphoma is associated with favorable clinical outcome.
Ekin Güney, Calixto-Hope G Lucas, Zhongxia Qi, Jingwei Yu, Ruth Zhang, James L Rubenstein

Blood Adv· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor metabolism and neurocognition in CNS lymphoma.
Huimin Geng, Mazie Tsang, Lakshmipriya Subbaraj, Joseph Cleveland, Lingjing Chen, James L Rubenstein

Neuro Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary central nervous system lymphoma in older adults and the rationale for maintenance strategies: a narrative review.
Mazie Tsang, James L Rubenstein, Elisa Jacobsen Pulczynski

Ann Lymphoma· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A functional mammalian display screen identifies rare antibodies that stimulate NK cell-mediated cytotoxicity.
Emily Kang, Cigall Kadoch, James L Rubenstein, Lewis L Lanier, James A Wells

Proc Natl Acad Sci U S A· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG).
Ramon F Barajas, Letterio S Politi, Nicoletta Anzalone, Heiko Schöder, Christopher P Fox, James L Rubenstein

Neuro Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood Coagulation Factor Fibrinogen in Tumor Pathogenesis of Central Nervous System B-Cell Lymphoma.
Justin P Chan, Mario Merlini, Hua-Xin Gao, Andrew S Mendiola, Katerina Akassoglou, James L Rubenstein

Am J Pathol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous T-Cell Lymphoma PDX Drug Screening Platform Identifies Cooperation between Inhibitions of PI3Kα/δ and HDAC.
Chi-Heng Wu, Chen-Yen Yang, Linlin Wang, Hua-Xin Gao, Taha Rakhshandehroo, James Rubenstein

J Invest Dermatol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On point in primary CNS lymphoma.
Mazie Tsang, Joseph Cleveland, James L Rubenstein

Hematol Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An audit of retinal lymphoma treatment at the University of California San Francisco.
Bertil Damato, Greg J Bever, Dan J Kim, Armin R Afshar, James L Rubenstein

Eye (Lond)· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose lenalidomide maintenance after induction therapy in older patients with primary central nervous system lymphoma.
Khoan Vu, Gabriel Mannis, Jimmy Hwang, Huimin Geng, James L Rubenstein

Br J Haematol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving Treatments for Primary Central Nervous System Lymphoma.
Andrés J M Ferreri, Matthias Holdhoff, Lakshmi Nayak, James L Rubenstein

Am Soc Clin Oncol Educ Book· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis